KG-FP-003
KG-FP-003 is a highly potent, selective, and durable TEAD PROTAC degrader (TEAD1 DC50 = 6 ± 4 nM, TEAD2 DC50 = 68 ± 15 nM, TEAD3 DC50 = 12 ± 5 nM, TEAD4 DC50 = 7 ± 5 nM). KG-FP-003 promotes ubiquitination and degradation of TEAD. KG-FP-003 exhibits anticancer activity against mesothelioma and ovarian cancer.
(Pink: TEAD ligand (HY-186118); Blue: Cereblon E3 ligase ligand; Black: linker).
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 3066008-42-9
- Fòrmula: C58H67ClF2N6O8
- Peso molecular:1049.64
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas YAP
MoreVer todos los productos específicos de isoformas PROTACs
More
Actividad biológica
Descripciòn
IC50 & Target
[1]|
Cereblon |
TEAD1 6 nM (DC50) |
TEAD2 68 nM (DC50) |
TEAD3 12 nM (DC50) |
TEAD4 7 nM (DC50) |
In Vitro
KG-FP-003 binds to recombinant CRBN-DDB1ΔBPB protein with an IC50 of 591 ± 21 nM[1].
KG-FP-003 (3-fold serial dilution starting at 10 μM; 2 h) binds to CRBN in HEK293T cells overexpressing NanoLuc-CRBN, with an IC50 of 962 ± 86 nM in the cellular binding assay[1].
KG-FP-003 (6 h) potently and selectively degrades all four TEAD isoforms in HiBiT-tagged HEK293T cells after 6 h of treatment (TEAD1 DC50 = 6 ± 4 nM, TEAD2 DC50 = 68 ± 15 nM, TEAD3 DC50 = 12 ± 5 nM, TEAD4 DC50 = 7 ± 5 nM)[1].
KG-FP-003 (72 h potently inhibits the proliferation of NCI-H226 mesothelioma cells, with an IC50 of 27 ± 7 nM after 72 h of treatment[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MSTO-211H mesothelioma cells
-
Concentration:300 nM
-
Incubation Time:Unclear
-
Result:Induced dramatic upregulation of the pro-apoptotic gene BMF and downregulation of the TEAD target gene CTGF.
-
Cell Line:MSTO-211H mesothelioma cells
-
Concentration:100-1000 nM
-
Incubation Time:24 h
-
Result:Increased the percentage of cells in G1 phase from 54.3% to 62.1% at 100 nM, and to 65.2% at 1000 nM, indicating G1 phase cell cycle arrest.
Parmacokinetics
In Vivo
KG-FP-003 (10-30 mg/kg; i.p.; once daily; 21 days) induces significant tumor regression in ES2 ovarian carcinoma xenografts at doses of 10 mg/kg and 30 mg/kg[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c nude (6-week-old)[1]
-
Dosage:3 mg/kg; 10 mg/kg; 30 mg/kg
-
Administration:i.p.; once daily; 21 days
-
Result:Induced pronounced degradation of TEAD1 protein and significant tumor growth inhibition compared to vehicle controls.
Achieved a tumor growth inhibition (TGI) rate of 118% at 10 mg/kg.
Achieved a TGI rate of 129% at 30 mg/kg.
Maintained stable body weights in all treated mice throughout the 21-day treatment period.
Chemical Information
-
No. CAS 3066008-42-9
-
Peso molecular 1049.64
-
Fòrmula C58H67ClF2N6O8
-
SMILES
CNC(C1=[C@](C(F)=C2C(C[C@@H]([C@@H]2O)C)=C1)[C@]3=C(C(F)=CC4=C3C[C@@](C5=CC=CC=C5)(O4)CNC6CCC(CC6)C(N7CCC(CC7)CC8CCN(CC8)C(COC9=CC=C(C(C)=C9)N%10CCC(NC%10=O)=O)=O)=O)Cl)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)